Objective: Uncrossable coronary lesions are still challenging to treat. Several devices and techniques are introduced, including rotational atherectomy, or anchor balloon. However, these methods are expensive, not always available, and associated with lower procedural success and higher major adverse cardiac events. Our study describes a simple, effective method [patience technique (PT)] to advance a stent through uncrossable lesions that has not been described in the literature. Material and Methods: In a prospective study with 24 patients undergoing uncrossable lesion percutaneous coronary intervention with stent advancement failures, we identify PT and describe our experience with PT. The PT is the process of pushing the uncrossed same stent for a prolonged time under an optimum constant force to overcome the intraluminal friction. Results: Twenty-three (95.8%) patients had modified American College of Cardiology/ American Heart Association classification Type C, 22 (91.70%) diffuse [median length: 38 mm (quartiles 31.25-52.25)], 22 (91.70%) eccentric and 20 (83.30%) moderate-extensive calcified lesions. Respectively, 8 (27.59%) of 29 stenosis was in left anterior descending, and right coronary artery, 6 (20.69%) left circumflex coronary artery, 3 (10.35%) D1, 2 (6.90%) left main coronary artery-Cx, 1 (3.45%) LCxOM2 and saphenous vein graft-LCxOM2. The median stent advancement time was 134.00 seconds (quartiles 95.25-178.50). All procedures progressed after using the PT and finally resulted successfully without complications. Conclusion: The PT is feasible, and safe for facilitating the passage of stents through uncrossable lesions. Before advancing percutaneous cardiac intervention techniques, this method could be used advantageously in calcified, diffuse, and eccentric lesions.
Keywords: Coronary artery disease; percutaneous coronary intervention
Amaç: Geçilemeyen koroner lezyonların tedavisi hâlen zorlayıcıdır. Bunun için rotasyonel aterektomi veya çapa balonu gibi çeşitli cihaz ve teknikler tanımlanmıştır. Ancak bu ve benzeri cihaz ve yöntemler pahalıdır, her zaman mevcut değildir, başarı oranları düşüktür, komplikasyon oranları yüksektir ve belirli koşullar altında uygulanabilmektedirler. Çalışmamızda, karmaşık yöntemlerden önce zorlayıcı geçilemeyen lezyonlarda stenti ilerletmek için basit, etkili, maliyetsiz, güvenli ve literatürde daha önce tanımlanmamış bir tekniği [sabır tekniği (ST)] açıklıyoruz. Gereç ve Yöntemler: Geçilmesi zor koroner lezyonların girişimi esnasında stent ilerletme işlemi başarısızlığa uğrayan 24 hasta üzerinde ileriye dönük çalışma ile yeni bir teknik tanımladık. ST, koroner arter ile stent arasındaki lümen içi sürtünme kuvvetinin üstesinden gelmek için optimum sabit bir kuvvet altında, periyodu uzatarak, uzun süre stenti itme işlemidir. Bulgular: Hastaların 23'ünde (%95,8) modifiye Amerikan Kardiyoloji Koleji/Amerikan Kalp Birliği sınıflandırması Tip C, 22'sinde (%91,70) yaygın [medyan lezyon uzunluğu: 38 mm (çeyrekler 31,25-52,25)], 22'sinde (%91,70) eksantrik ve 20'sinde (%83,30) orta-ileri düzeyde kalsifiye lezyonlar mevcuttu. Yirmi dokuz lezyonun 8'inde (%27,59) sağ koroner arter ve sol ön inen koroner arter, 6'sında (%20,69) sol sirkumfleks koroner arter, 3'ünde (%10,35) D1, 2'sinde (%6,90) sol ana koroner arter-Cx, 1'inde (%3,45) LCxOM2 ve safen ven greft lezyonları izlendi. Ortanca stent ilerletme süresi 134,00 sn (çeyrekler 95,25-178,50) saptandı. ST kullandıktan sonra tüm koroner girişimsel işlemleri komplikasyonsuz olarak başarıyla sonuçlandırıldı. Sonuç: Stentin geçirilmesi zor, eksantrik, diffüz ve ileri kalsifik koroner lezyonlarda, stent geçişini kolaylaştırmak için karmaşık yöntemlere geçmeden önce başarılı ve güvenilir bir yöntem olan ST kullanılabilir.
Anahtar Kelimeler: Koroner arter hastalığı; perkütan koroner girişim
- Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. EuroIntervention. 2019;14(14):1435-534. [Crossref] [PubMed]
- Dash D. Interventional management of "Balloon-Uncrossable" coronary chronic total occlusion: is there any way out? Korean Circ J. 2018;48(4):277-86. [Crossref] [PubMed] [PMC]
- McQuillan C, Jackson MWP, Brilakis ES, Egred M. Uncrossable and undilatable lesions-A practical approach to optimizing outcomes in PCI. Catheter Cardiovasc Interv. 2021;97(1):121-6. [Crossref] [PubMed]
- Karacsonyi J, Kostantinis S, Simsek B, Rempakos A, Allana SS, Alaswad K, et al. Angiographic features and clinical outcomes of balloon uncrossable lesions during chronic total occlusion percutaneous coronary intervention. J Pers Med. 2023;13(3):515. [Crossref] [PubMed] [PMC]
- Salem H, Mintz GS, Matsumura M, Zhang M, Usui E, Seike F, et al. Reasons for lesion uncrossability as assessed by intravascular ultrasound. Catheter Cardiovasc Interv. 2022;99(7):2028-37. [Crossref] [PubMed]
- Gündüz R, Yıldız BS, Çetin N, Özgür S, Çizgici AY, Tülüce K, et al. Multi-center experience of coronary artery perforation during percutaneous coronary intervention: clinical and angiographic characteristics, management, and outcomes between 2010 and 2020. Anatol J Cardiol. 2022;26(8):608-18. [PubMed] [PMC]
- Gioia GD, Morisco C, Barbato E. Severely calcified coronary stenoses: novel challenges, old remedy. Postepy Kardiol Interwencyjnej. 2018;14(2):115-6. [Crossref] [PubMed] [PMC]
- Chawla R, Ahamad W, Sharma V. Techniques to overcome difficulty in device deliverability to lesion in complex PCI. Curr Cardiol Rev. 2020;16(2):117-24. [Crossref] [PubMed] [PMC]
- Srivastava V, Rastogi R. Blood flow through a stenosed catheterized artery: Effects of hematocrit and stenosis shape. Computers & Mathematics with Applications. 2010;59(4):1377-85. [Crossref]
- Serway RA, Jewett JW. Physics for Scientists and Engineers: Cengage Learning. 10th ed. Australia: Brooks/Cole; 2018.
- Hibbeler RC. Chapter 15: Kinetics of a particle: Impulse and momentum. Engineering Mechanics Combined Statics and Dynamics. 12th ed. USA: Prentice Hall; 2010. p.222.
- Nakano K, Popov VL. Dynamic stiction without static friction: the role of friction vector rotation. Phys Rev E. 2020;102(6-1):063001. [Crossref] [PubMed]
- Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78(2):486-502. [Crossref] [PubMed]
- Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82(4):1193-202. [Crossref] [PubMed]
- Ishibashi S, Sakakura K, Asada S, Taniguchi Y, Jinnouchi H, Tsukui T, et al. Factors associated with difficulty in crossing the culprit lesion of acute myocardial infarction. Sci Rep. 2021;11(1):21403. [Crossref] [PubMed] [PMC]
- Redwood S, Curzen N, Banning A. Oxford Textbook of Interventional Cardiology. 2nd ed. Oxford: Oxford University Press; 2018. [Crossref]
- Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 7;40(2):87-165. Erratum in: Eur Heart J. 2019;40(37):3096. [Crossref] [PubMed]
- Smith DL, Heldt JP, Richards GD, Agarwal G, Brisbane WG, Chen CJ, et al. Radiation exposure during continuous and pulsed fluoroscopy. J Endourol. 2013;27(3):384-8. [Crossref] [PubMed]
- Bourassa MG, Lespérance J, Eastwood C, Schwartz L, Côté G, Kazim F,et al. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1991;18(2):368-76. [Crossref] [PubMed]
- Burzotta F, Mortier P, Trani C. Characteristics of drug-eluting stent platforms potentially influencing bifurcated lesion provisional stenting procedure. EuroIntervention. 2014;10(1):124-32. [Crossref] [PubMed]
- Baris N, Akdeniz B, Uyar S, Ozel E, Kirimli O, Badak O, et al. Are complex coronary lesions more frequent in patients with diabetes mellitus? Can J Cardiol. 2006;22(11):935-7. [Crossref] [PubMed] [PMC]
- Iwasaki K, Matsumoto T, Aono H, Furukawa H, Nagamachi K, Samukawa M. Distribution of coronary atherosclerosis in patients with coronary artery disease. Heart Vessels. 2010;25(1):14-8. [Crossref] [PubMed]
- Goel M, Wong ND, Eisenberg H, Hagar J, Kelly K, Tobis JM. Risk factor correlates of coronary calcium as evaluated by ultrafast computed tomography. Am J Cardiol. 1992;70(11):977-80. [Crossref] [PubMed]
- Copeland-Halperin RS, Baber U, Aquino M, Rajamanickam A, Roy S, Hasan C, et al. Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry. Catheter Cardiovasc Interv. 2018;91(5):859-66. [Crossref] [PubMed]
- De Maria GL, Scarsini R, Banning AP. Management of calcific coronary artery lesions: is it time to change our interventional therapeutic approach? JACC Cardiovasc Interv. 2019;12(15):1465-78. [Crossref] [PubMed]
- Caiazzo G, Di Mario C, Kedhi E, De Luca G. Current management of highly calcified coronary lesions: an overview of the current status. J Clin Med. 2023;12(14):4844. [Crossref] [PubMed] [PMC]
- Cialdella P, Sergi SC, Zimbardo G, Donahue M, Talarico GP, Lombardi d'Aquino UM, et al. Calcified coronary lesions. Eur Heart J Suppl. 2023;25(Suppl C):C68-C73. [Crossref] [PubMed] [PMC]
- Yue X, Guo J, Zhang J, Cao C, Zhang Z, Shen D, et al. Evaluation of Mechanical Performances of Stents with 38 mm Length in Long Lesion. Biomed Res Int. 2020;2020:2594161. [Crossref] [PubMed] [PMC]
.: Process List